PeerVoice Oncology & Haematology Audio-logo

PeerVoice Oncology & Haematology Audio

Education Podcasts

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Location:

United States

Description:

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

Personalising Management of Advanced RCC: How I Treat

5/16/2022
Personalising Management of Advanced RCC: How I Treat

Duration:00:09:19

‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B

5/16/2022
‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B

Duration:00:18:44

Immunotherapeutic Approaches in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Insights From the Real World

5/5/2022
Immunotherapeutic Approaches in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Insights From the Real World

Duration:00:11:42

A Clinical Conversation on Metastatic Hormone-Sensitive Prostate Cancer: Intensifying Therapy Earlier in the Disease Course

4/26/2022
A Clinical Conversation on Metastatic Hormone-Sensitive Prostate Cancer: Intensifying Therapy Earlier in the Disease Course

Duration:00:38:34

Complex Cases of Comorbidities in Patients With HCV

4/21/2022
Complex Cases of Comorbidities in Patients With HCV

Duration:00:20:20

"Defining the Diagnosis and Management of Pyruvate Kinase Deficiency"

4/20/2022
"Defining the Diagnosis and Management of Pyruvate Kinase Deficiency"

Duration:00:21:02

Applying Revised Treatment Guidelines for Advanced Hepatocellular Carcinoma: Considerations in Real-Life Practice

3/1/2022
Applying Revised Treatment Guidelines for Advanced Hepatocellular Carcinoma: Considerations in Real-Life Practice

Duration:00:17:05

The Place of Radiopharmaceuticals in an Evolving Treatment Landscape: Addressing Perceptions With Clinical Evidence to Optimise Outcomes in Men With Metastatic Prostate Cancer

2/28/2022
The Place of Radiopharmaceuticals in an Evolving Treatment Landscape: Addressing Perceptions With Clinical Evidence to Optimise Outcomes in Men With Metastatic Prostate Cancer

Duration:00:28:12

Updates on PARP Inhibitors From ESGO 2021

1/24/2022
Updates on PARP Inhibitors From ESGO 2021

Duration:00:13:55

Optimising Outcomes With PARPs: Cases in Advanced Ovarian Cancer

1/24/2022
Optimising Outcomes With PARPs: Cases in Advanced Ovarian Cancer

Duration:00:29:08

"Implementing a Radioligand Strategy for mCRPC: Your Clinical Questions"

1/24/2022
"Implementing a Radioligand Strategy for mCRPC: Your Clinical Questions"

Duration:00:35:11

"The Changing Landscape for SCAC: What Clinicians Need to Know Now"

1/24/2022
"The Changing Landscape for SCAC: What Clinicians Need to Know Now"

Duration:00:19:24

Ensuring Long-Term Success in Advanced Ovarian Cancer: Sequencing Therapy Based on Science

1/6/2022
Ensuring Long-Term Success in Advanced Ovarian Cancer: Sequencing Therapy Based on Science

Duration:00:43:01

Quality of Life in Patients With Advanced Renal Cell Carcinoma: Are We Measuring What Matters?

12/20/2021
Quality of Life in Patients With Advanced Renal Cell Carcinoma: Are We Measuring What Matters?

Duration:00:23:29

Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy

12/20/2021
Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy

Duration:00:25:12

Current and Emerging Radiopharmaceuticals for Prostate Cancer: Is There a Role for Both?

12/17/2021
Current and Emerging Radiopharmaceuticals for Prostate Cancer: Is There a Role for Both?

Duration:01:27:11

Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies

11/29/2021
Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies

Duration:00:56:33

Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?

11/12/2021
Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?

Duration:00:19:35

Optimising Outcomes With PARPs in Advanced Ovarian Cancer

11/10/2021
Optimising Outcomes With PARPs in Advanced Ovarian Cancer

Duration:00:12:04

Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses

10/26/2021
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses

Duration:00:05:13